Home524715 • BOM
add
Sun Pharmaceutical Industries Ltd
Previous close
₹1,720.00
Day range
₹1,636.30 - ₹1,688.95
Year range
₹1,376.75 - ₹1,960.20
Market cap
4.04T INR
Avg Volume
68.66K
P/E ratio
35.27
Dividend yield
0.92%
Primary exchange
NSE
In the news
SUNPHARMA
1.72%
Financials
Income Statement
Revenue
Net income
(INR) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 136.75B | 10.46% |
Operating expense | 73.73B | 6.65% |
Net income | 29.03B | 15.04% |
Net profit margin | 21.23 | 4.17% |
Earnings per share | 13.21 | 22.65% |
EBITDA | 41.51B | 25.15% |
Effective tax rate | 16.10% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 201.22B | 35.66% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 693.80B | — |
Shares outstanding | 2.40B | — |
Price to book | 5.96 | — |
Return on assets | — | — |
Return on capital | 12.38% | — |
Cash Flow
Net change in cash
(INR) | Dec 2024info | Y/Y change |
---|---|---|
Net income | 29.03B | 15.04% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world.
Around 70% of Sun Pharma’s revenue is generated from international markets. The US and India are the largest markets, accounting for over 60% of the company's turnover. Manufacturing is across 43 locations in India, the US, Asia, Africa, Australia and Europe. The products cater to therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. Its active pharmaceutical products include baricitinib, brivaracetam, and dapaglifozin. Wikipedia
Founded
1983
Headquarters
Website
Employees
43,000